Ligand validation:2R85

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 2R85 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2R85_AMP_A_400	96%	43%	0.062	0.971	1.07	1.2	2	1	0	0	100%	1
2R85_AMP_B_400	77%	43%	0.089	0.928	1.01	1.22	1	2	0	0	100%	1
2R85_AMP_A_401	42%	39%	0.214	0.936	1.08	1.38	2	3	0	0	100%	1
2R85_AMP_B_401	32%	40%	0.259	0.933	1.07	1.34	2	2	0	0	100%	1
2R84_AMP_A_400	70%	43%	0.109	0.927	1.04	1.23	1	2	0	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	42%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	42%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5NRH_AMP_B_700	99%	36%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1
4M0K_AMP_D_300	99%	41%	0.047	0.983	0.89	1.43	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.